Jianmin Pharmaceuticals
1
11M
1
1
- Areas of investment
Summary
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2016. The common things for fund are deals in the range of 10 - 50 millions dollars.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Medical. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Fe3 Medical, Fe3 Medical.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Jianmin Pharmaceuticals, startups are often financed by Ping An Ventures, Hg. The meaningful sponsors for the fund in investment in the same round are Ping An Ventures, Hg. In the next rounds fund is usually obtained by Ping An Ventures, Hg.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Investments by industry
- Biotechnology (1)
- Medical (1)
- Health Care (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Fe3 Medical | 02 Mar 2016 | Biotechnology, Health Care, Medical | Early Stage Venture | 11M | United States, California, San Jose |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.